Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Microplate Designed for High-Resolution Microscopy

By BiotechDaily International staff writers
Posted on 12 Mar 2013
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
A new, black 96-well microplate includes an ultra-low well base that enables high-magnification microscopy, inclusive of perimeter wells, even with a minimum working distance.

Greiner Bio-One (Frickenhausen, Germany) now expands its microplate portfolio with the introduction of “ScreenStar” at the 2013 Society for Laboratory Automation and Screening (SLAS) conference exhibition in Orlando (FL, USA). The ScreenStar design includes several new features. Manufactured entirely of cycloolefin, an innovative material with glass-like optical properties, it facilitates outstanding image quality of well contents. The microplate has a 190 μm ultraclear film bottom. The key advantage of ScreenStar over other plates for high-resolution microscopy is the extremely short distance between the well bottom and the microplate skirt (internal well to skirt bottom = 0.7 mm; external well to skirt bottom = 0.51 mm), rendering ease of high magnification microscopy at perimeter wells without complex microscopic adjustments. The circular wells allow microscopic work without disruptive shadow using the smallest possible meniscus lens. The perimeter ditch can be filled with water or medium to reduce edge effect due to evaporation, especially for long incubation periods. A proven cell culture-treatment quality ensures reliable, uniform growth.

The black, 96-well, 190 μm clear film bottom, cell culture treated, cycloolefin ScreenStar microplate comes sterile with lid, individually packed. Well bottoms are protected by a film that must be removed prior to use. The identical microscopy plate with a glass bottom will be introduced shortly.

Related Links:
Greiner Bio-One



Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.